Home/Empiriko/Pam Randhawa
PR

Pam Randhawa

CEO & Founder

Empiriko

Empiriko Pipeline

DrugIndicationPhase
R*ECL-AI-M Platform TherapeuticsCancerPre-clinical
PMF™ Diagnostic DeviceCancer Treatment Monitoring & Cardiovascular RiskDevelopment